Published: September 2021
In the ongoing COVID-19 pandemic, a surge in the number of research studies has been observed, presenting lucrative opportunities for biospecimen service providers having the capabilities to offer high-quality biospecimens and associated analytical services
Given the growing number of research and development initiatives in the pharmaceutical industry, and the rising number of clinical trials, the demand for high-quality biological samples has increased. The increasing demand has led to the emergence of new challenges faced during the procurement and evaluation of biospecimens. As a result, several pharmaceutical, biopharmaceutical and researchers have opted to outsource their biospecimen analytical services.
To order this 125+ page report, which features 55+ figures and 80+ tables, please visit https://www.rootsanalysis.com/reports/biospecimen-contract-research-services-market.html
Presently, more than 40 companies claim to offer research services for biospecimens
The biospecimen contract research services market is highly fragmented, featuring a mix of small, mid-sized and large players. Of these, more than 70% of the biospecimen contract research service providers are headquartered in North America and majority claim of offer services for both plasma and serum.
Over 70 partnerships were established in this domain, during the period 2015-2021
Majority of the deals recorded in the report were established in 2019 and 2020. Further, majority of the deals (~30%) were inked for the acquisition / merger purposes, followed by service agreements, accounting of more than 20% of the partnerships.
Several commercial banks based in different regions of the world offer procurement services on contractual basis
More than 60% of the commercial biobanks are headquartered in North America, followed by those which are headquartered in Europe (~25%). Further, close to 90% of the commercial banks offer biospecimens for oncological studies.
By 2030, the opportunity within the biospecimen contract research services market is likely to be dominated by the North America
Presently, the use of biospecimen contract research services is largely restricted to the developed nations, and the majority of revenues via outsourcing is distributed between North America (~45%) and Asia-Pacific (~30%).
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/biospecimen-contract-research-services-market/request-sample.html
By 2030, the financial opportunity associated with biospecimen contract research services market has been analyzed across the following segments:
The report also features inputs from eminent industry stakeholders, according to whom, in terms of growth rate, biospecimen contract research services market is likely to witness a significant increase in the near future. The report includes detailed transcripts of discussions held with the following experts:
The research includes profiles of key players offering a wide range of research services for the biospecimens across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, details on its biospecimen related services offered, types of blood products offered, types of human tissues offered, types of other biospecimens offered, types of analytical services offered, types of samples offered, geographic availability of the services, recent developments and an informed future outlook.
For additional details, please visit
https://www.rootsanalysis.com/reports/biospecimen-contract-research-services-market.html or email firstname.lastname@example.org
You may also be interested in the following titles:
1. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030
2. Lipid Contract Manufacturing Market: Industry Trends and Global Forecasts, 2021-2030
3. Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
4. Vaccine Contract Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, 2021-2030
+1 (415) 800 3415
+44 (122) 391 1091
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES